THE MISCH INSTITUTE NEWSLETTER IN MEMORIUM It is with heavy hearts today that we say farewell to one of our close Resnik Implant Institute family members, Dr. Michael D. Ginder of Athens, Ohio. He was a Misch graduate and a favorite of the faculty and staff. He not only was an excellent clinician, he was […]
[vc_row us_bg_image=”3115″ us_bg_size=”contain” us_bg_repeat=”no-repeat” el_class=”masthead-newsletter” us_bg_image_source=”media”][vc_row el_class=”newsletter-row”] THE MISCH INSTITUTE NEWSLETTER [vc_row color_scheme=”alternate” el_class=”newsletter-content”][vc_column width=”1/2″ el_class=”orange-right”] New Prophylactic Antibiotic Protocol for Sinus Graft Procedures [us_image image=”3123″ align=”center”]For years, Augmentin (Amoxicillin-clavulanate) has been used as the first line antibiotic for the therapeutic and prophylactic treatment of sinus graft procedures because of its superior beta-lactamase coverage. With […]
[vc_row us_bg_image=”3115″ us_bg_size=”contain” us_bg_repeat=”no-repeat” el_class=”masthead-newsletter” us_bg_image_source=”media”][vc_row el_class=”newsletter-row”] THE MISCH INSTITUTE NEWSLETTER [vc_row color_scheme=”alternate” el_class=”newsletter-content”][vc_column width=”1/2″ el_class=”orange-right”] Beware of the Complications of a New Drug Class: The “Biologics” A new class of therapeutic drugs are becoming more popular in the treatment of an array of medical conditions such as autoimmune disease and cancers. These new drugs […]